World

Iran says Blinken's anti-Iran remarks aimed at selling U.S. weapons

Apr 24, 2023

Tehran [Iran], April 24: The Iranian Foreign Ministry spokesman on Sunday rebuked the remarks by the U.S. secretary of state about Tehran's military program, saying they are aimed at marketing American weapons.
Nasser Kanaani made the response to a recent tweet by Antony Blinken, in which he said that they were "firmly committed to disrupting Iran's military procurement activities," according to a statement published on the Iranian Foreign Ministry's website.
"The U.S. state secretary's provocative remarks about Iran's military program are solely aimed at continuing marketing American armaments through spreading Iranophobia as well as sowing discord among regional countries," Kanaani said.
He reiterated that Iran's military program is "defensive and deterrent" in nature and not against any country that does not harbor the idea of "aggression" against Iran.
Kanaani blamed the U.S. "unwise and erroneous" actions over the past decades as the sources of insecurity, instability and wars in the region, adding it will be in the U.S. interest if it stops its "wrong, meddlesome and irresponsible" approaches toward the regional countries.
Source: Xinhua

More news

Metropolis Healthcare unveils Key Findings from Molecular Genomics Study in honour of Lung Cancer Awareness Month

Mumbai (Maharashtra) [India], November 22: Lung cancer remains one of the most prevalent and deadly cancers globally, with approximately 2.2 million new cases diagnosed annually, contributing to 18% of all cancer-related deaths, according to the International Agency for Research on Cancer. In India, it continues to be a leading cause of cancer-related mortality. However, advancements in early detection and new treatment options, particularly genetic profiling, are improving survival rates. These innovations are part of precision oncology, a rapidly growing field that customizes treatments based on a patient's unique genetic makeup, enabling personalized care.

Nov 22, 2024